Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Sep 16, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-09-13$6.26/sh−5,312$33,254→ 153,616 total(indirect: By Spouse)
Holdings
- 351,510
Common Stock
- 77,592(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Transaction was executed in multiple trades in prices ranging from $6.2601 to $6.265, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote
- [F2]Reflects the adjusted total which includes the purchase of 2,676 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.
- [F3]The shares are directly held by the Reporting Person's wife.
- [F4]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.